Kura Oncology, Inc.
USD10.89
+0.21 (+1.97%)
CEO
Troy Wilson
IPO Date
2015-09-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.63
Prev. Close
$10.68
Day Low
$10.49
Day High
$10.92
52W Low
$5.45
52W High
$12.49
Market Cap
$0.97B
Volume
1.22M
| 35,000 |
| $8.77 |
| 4 Jun 2026 | VASCONCELLES MICHAEL | director | A-Award | Acquired | 35,000 | $8.77 |
| 4 Jun 2026 | Hasnain Faheem | director | A-Award | Acquired | 35,000 | $8.77 |
| 4 Jun 2026 | Collins Helen Louise | director | A-Award | Acquired | 35,000 | $8.77 |
| 4 Jun 2026 | SCHAFER CAROL | director | A-Award | Acquired | 35,000 | $8.77 |
| 4 Jun 2026 | Szela Mary T | director | A-Award | Acquired | 35,000 | $8.77 |
| 4 Jun 2026 | Malley Thomas | director | A-Award | Acquired | 35,000 | $8.77 |
| 22 May 2026 | Powl Brian T. | Chief Commercial Officer | S-Sale | Disposed | 10,000 | $11.00 |
| 20 May 2026 | Powl Brian T. | Chief Commercial Officer | S-Sale | Disposed | 339 | $9.21 |